| Chemotherapy, Gemzar (gemcitabine for injection) Gemzar is a chemotherapy drug used to treat non small cell lung cancer, pancreatic cancer, metastatic breast cancer, and ovarian cancer Read More |
| Gemzar Information from Drugs.com Gemzar (gemcitabine) is used to treat cancers of the pancreas, lung, breasts and ovaries. Includes Gemzar side effects, interactions and indications. Read More |
| Gemcitabine - Wikipedia, the free encyclopedia Gemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar by Eli Lilly and Company. Chemically gemcitabine is a nucleoside analog in which the ... Read More |
| Gemzar & Gemzar Side Effects - Chemotherapy Drugs Gemzar is the trade name for the generic chemotherapy drug Gemcitabine. Gemzar is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug and is classified as ... Read More |
| Gemzar Official FDA information, side effects and uses. Accurate, FDA approved Gemzar information for healthcare professionals and patients - brought to you by Drugs.com. Read More |
| Gemzar Information: Description, Side Effects and Gemzar Treatment Gemzar is an anticancer drug that affects cell division in cancers of the ovaries, pancreas, lungs, and breasts. Learn more about Gemzar treatment at cancercenter.com. Read More |
| Contact Us, Eli Lilly and Company - Gemzar.com Contact Us - Gemzar.com. If you have any additional questions about Gemzar, please feel free to contact Eli Lilly and Company. Read More |
| Gemzar (Gemcitabine Hcl) Drug Information: Description, User ... Learn about the prescription medication Gemzar (Gemcitabine Hcl), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Gemzar( (gemcitabine) Injection, Eli Lily and Company HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing ... Read More |
| GEMZAR (gemcitabine for injection) — Advanced Ovarian Cancer ... GEMZAR is indicated for the treatment of advanced ovarian cancer, advanced NSCLC, metastatic breast cancer, and advanced pancreatic cancer. Read More |
